While these exhausted Tregs remain suppressive in vitro, they may lose their immunomodulatory functions in vivo [37–39], potentially accounting for the diminished impact on modifying inflammatory mediators, AD biomarkers and clinical decline in the IL-2 q2wks arm. Here, IL2 is linked to Alzheimer disease.